Ignite Creation Date:
2024-05-06 @ 3:58 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04829669
Status:
WITHDRAWN
Last Update Posted:
2024-04-24
First Post:
2021-03-31
Brief Title:
A Study of Participants With Moderate or Severe Major Depressive Disorder MDD Requiring Urgent Symptom Control in a Psychiatric Emergency
Sponsor:
Janssen-Cilag Ltd
Organization:
Janssen-Cilag Ltd
Study Overview
Official Title:
Prospective Study to Assess Outcomes and Healthcare Resource Use of Current Standard of Care for Patients With Moderate or sEvere MDD Requiring Urgent Symptom Control in a Psychiatric Emergency POWER
Status:
WITHDRAWN
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The study has faced delays in the last years due to unforeseen challenges - the COVID-19 pandemic and recruitment of a sensitive population Janssen have tried to continue the study but new challenges have now led to the cancellation of this study
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
POWER
Brief Summary:
The purpose of the study is to describe the clinical outcomes severity of depression severity of suicidality frequency of suicidal thinking suicide events and quality of life QoL of participants with symptoms of major depressive disorder MDD that have current suicidal ideation with intent
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 54135419MDD4003 | OTHER | Janssen-Cilag Ltd | None |